Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck
BACKGROUND: concurrent chemoradiotherapy is the standard treatment for patients with advanced head and neck squamous cell carcinoma (HNSCC). The present study was carried to assess the feasibility and efficacy of low dose Gemcitabine as a radiosensitizer when used during radical therapeutic management of patients with locally advanced HNSCC. PATIENTS AND METHODS: Fifty-two patients with locally advanced HNSCC (stage III, 50%; ... Read more